Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Black Diamond Therapeutics (BDTX) Capital Expenditures: 2019-2021

Historic Capital Expenditures for Black Diamond Therapeutics (BDTX) over the last 3 years, with Dec 2021 value amounting to $333,000.

  • Black Diamond Therapeutics' Capital Expenditures rose 205.50% to $333,000 in Q4 2021 from the same period last year, while for Dec 2021 it was $2.7 million, marking a year-over-year increase of 1781.94%. This contributed to the annual value of $33,000 for FY2023, which is 82.81% down from last year.
  • Latest data reveals that Black Diamond Therapeutics reported Capital Expenditures of $333,000 as of Q4 2021, which was down 71.73% from $1.2 million recorded in Q3 2021.
  • Over the past 5 years, Black Diamond Therapeutics' Capital Expenditures peaked at $1.2 million during Q3 2021, and registered a low of -$2,000 during Q2 2019.
  • Its 3-year average for Capital Expenditures is $261,182, with a median of $25,000 in 2020.
  • In the last 5 years, Black Diamond Therapeutics' Capital Expenditures decreased by 27.27% in 2020 and then skyrocketed by 14,625.00% in 2021.
  • Quarterly analysis of 3 years shows Black Diamond Therapeutics' Capital Expenditures stood at $2,000 in 2019, then soared by 5,350.00% to $109,000 in 2020, then soared by 205.50% to $333,000 in 2021.
  • Its last three reported values are $333,000 in Q4 2021, $1.2 million for Q3 2021, and $814,000 during Q2 2021.